HIF1A and non-small cell lung carcinoma: Combining the above functional enrichment analysis results, we identified hypoxia, HIF-1 pathway, and PD-L1-related signaling pathway as critical pathways to PD-1 or PD-L1 treatment responses in NSCLC.